Introduction Qelbree is the brand name of viloxazine extended-release, a non-stimulant drug used for the treatment of attention-deficit/hyperactivity disorder, commonly called ADHD. It is indicated for ADHD in adults and pediatric patients 6 years of age and older. Qelbree is pharmacologically important because it is different from stimulant ADHD medicines such as methylphenidate and amphetamine … Read more
Introduction Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant widely used in the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. Unlike selective serotonin reuptake inhibitors (SSRIs), venlafaxine enhances both serotonergic and noradrenergic neurotransmission, providing broader modulation of mood-regulating pathways. Venlafaxine is often considered a dual-action antidepressant because its … Read more
